Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-Hormone Closed-Loop Glucose Control in Adolescents with Type 1 Diabetes
2020-005836-31Phase 4Terminated
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin and glucagon in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Time below range <3.9 mmol/L. Started Feb 2021; status: terminated.
02
Drugs
human insulinglucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2020-005836-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005836-31.